Skip to content
Homepage
Author:
Sibel Health
Posted Date:
June 10, 2026
Sibel Health Receives EU MDR Class IIb CE Mark for ANNE® One: The First Wireless Wearable Patient Monitoring Platform Certified to Key Interoperability Standards
Sibel Health
June 10, 2026
Sibel Health Awarded a $3.5 million ARPA-H Direct-to-Phase II SBIR Contract to Develop a First-In-Class Wearable Sensor for Continuous Edema Monitoring
Sibel Health
April 27, 2026
Sibel Health Receives FDA-Clearance for ANNE® Maternal, a Comprehensive and Fully Wireless Maternal-Fetal Monitoring Platform
Sibel Health
April 9, 2026
Sibel Health and LookDeep Health Announce Strategic Partnership to Combine Continuous Vitals with Real-Time Bedside AI – Without Lock-In
Sibel Health
February 25, 2026
Sibel Health Receives FDA Acceptance into Drug Development Tool Qualification Program for Innovative Cough Monitoring Sensor
Sibel Health
February 19, 2026
